ArticleRSC advances2023
Study of electrospun nanofibers loaded with Ru(ii) phenanthroline complexes as a potential material for use in dye-sensitized solar cells (DSSCs).
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications.Pharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dye-sensitized solar cells (DSSCs) are an increasingly attractive alternative energy source because of their low cost. Therefore, researchers have intensified efforts over the past decade to increase their energy conversion efficiency by employing new materials in each DSSC component. The present research focuses on synthesizing electrospun nanofibers as a potential new material as a counter electrode in DSSCs. Two Ru(ii) half sandwich 1,10 phenanthroline (phen) Ru-1 and 5-amino- phen Ru-2 complexes were prepared for its functionalization. As a deposition medium, poly(caprolactone) (PCL) dissolved in chloroform was used. Different Ru(ii) complex concentrations were made at 0.1% wt., 0.5% wt., and 1% wt. Thermal characterization studies using differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) were conducted to evaluate the behavior and weight loss of the samples with temperature variations. Fourier transform infrared spectroscopy (FTIR) measurements were taken to observe the bond interaction of the ruthenium complexes and the PCL. Finally, scanning electron microscopy (SEM) was used to structurally and morphologically evaluate the fiber distribution and porosity. These fibers have a homogeneous morphology, without bulbs, but with evident solid inlays on the surface, with fibers between ∼0.58 to 2.47 μm and percentages of porosity ∼45%. TGA and DSC thermograms show minor temperature variations that demonstrate the incorporation of the Ru(ii) complexes into the fiber. Furthermore, the melting and degradation temperature of the fibers is suitable for use in a DSSC approach. The incorporation of the ruthenium compounds into PCL fibers, along with the addition of the NH
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.